LakeShore Biopharma Co., Ltd (LSB)
USD 1.19
(-4.8%)
USD 1.19
(-4.8%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -445.83 Million CNY | -219.86% |
| 2022 | -139.38 Million CNY | -25280.09% |
| 2021 | -549.18 Thousand CNY | 99.56% |
| 2020 | -125.84 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q4 | -25.05 Million USD | -110.9% |
| 2023 FY | -445.83 Million CNY | -219.86% |
| 2023 Q3 | -11.87 Million USD | 89.51% |
| 2023 Q2 | -113.2 Million CNY | -61.6% |
| 2023 Q1 | -70.05 Million CNY | -555.2% |
| 2022 Q3 | -6.97 Million USD | -742.01% |
| 2022 Q1 | -410.67 Thousand USD | -75.73% |
| 2022 Q2 | -828.46 Thousand USD | -101.73% |
| 2022 FY | -139.38 Million CNY | -25280.09% |
| 2022 Q4 | -10.69 Million USD | -53.27% |
| 2021 Q1 | -40.33 Thousand USD | 0.0% |
| 2021 FY | -549.18 Thousand CNY | 99.56% |
| 2021 Q4 | -233.7 Thousand USD | 22.7% |
| 2021 Q3 | -302.31 Thousand USD | -48.99% |
| 2021 Q2 | -202.9 Thousand USD | -403.1% |
| 2020 FY | -125.84 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Absci Corporation | -115.51 Million USD | -285.952% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -96.372% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -57.999% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -4386.299% |
| Apollomics, Inc. | -54.83 Million USD | -713.059% |
| 180 Life Sciences Corp. | -13.47 Million USD | -3207.976% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1320.89% |
| Bicycle Therapeutics plc | -189.94 Million USD | -134.715% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -431.297% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -159.534% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -1663.578% |
| Chimerix, Inc. | -93.06 Million USD | -379.055% |
| CRISPR Therapeutics AG | -222.53 Million USD | -100.34% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 2873.108% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -505.241% |
| Fortress Biotech, Inc. | -142.34 Million USD | -213.212% |
| Fortress Biotech, Inc. | -142.34 Million USD | -213.212% |
| Gritstone bio, Inc. | -154.63 Million USD | -188.315% |
| Allakos Inc. | -196.05 Million USD | -127.401% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -713.622% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -266.955% |
| Cytokinetics, Incorporated | -496.2 Million USD | 10.152% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -1610.792% |
| Innoviva, Inc. | 176.7 Million USD | 352.298% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -5695.872% |
| NLS Pharmaceutics AG | -11.8 Million USD | -3675.981% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -250.878% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -3457322.074% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -334.713% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -401.691% |
| ImmuCell Corporation | -5.74 Million USD | -7656.201% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -231.649% |
| Incyte Corporation | 620.52 Million USD | 171.848% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -229.693% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -6723.248% |
| Mustang Bio, Inc. | -50.72 Million USD | -778.903% |
| MiMedx Group, Inc. | 37.11 Million USD | 1301.187% |
| MEI Pharma, Inc. | 14.54 Million USD | 3165.827% |
| MacroGenics, Inc. | -168.24 Million USD | -164.992% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -4948.36% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1468.949% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -2957.547% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -239.075% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1308.723% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -1828.377% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2706.449% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -3600.162% |
| NextCure, Inc. | -67.63 Million USD | -559.155% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -765.593% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -4120.7% |
| Onconetix, Inc. | -36.03 Million USD | -1137.235% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -968.784% |
| Opthea Limited | -191.84 Million USD | -132.395% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -652.061% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -16101.339% |
| PDS Biotechnology Corporation | -43.04 Million USD | -935.73% |
| Precigen, Inc. | -88.92 Million USD | -401.369% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1398.294% |
| Prime Medicine, Inc. | -191.29 Million USD | -133.064% |
| PureTech Health plc | -146.19 Million USD | -204.949% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -71.699% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 111.016% |
| Replimune Group, Inc. | -234.77 Million USD | -89.899% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5050.165% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -2075.748% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -2195.914% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 8.488% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1734.203% |
| Sesen Bio, Inc. | -25.9 Million USD | -1620.763% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -62.71% |
| Solid Biosciences Inc. | -104.31 Million USD | -327.391% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -93.879% |
| SciSparc Ltd. | -5.77 Million USD | -7622.718% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -399.376% |
| TG Therapeutics, Inc. | 20.63 Million USD | 2260.774% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -276.611% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -6026.598% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -18.338% |
| UroGen Pharma Ltd. | -65.53 Million USD | -580.286% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -577.979% |
| XOMA Corporation | -41.84 Million USD | -965.362% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -79.058% |
| AbCellera Biologics Inc. | -237.2 Million USD | -87.951% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -685.483% |
| Cassava Sciences, Inc. | -105.95 Million USD | -320.767% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -889.04% |
| Precision BioSciences, Inc. | -43.73 Million USD | -919.372% |
| Dyadic International, Inc. | -8.22 Million USD | -5317.335% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -5259.208% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -37302.056% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1423.797% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -239.829% |
| IGM Biosciences, Inc. | -263.46 Million USD | -69.221% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -314.643% |
| Acelyrin, Inc. | -422.06 Million USD | -5.631% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -845.863% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 3833.315% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -2119.199% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -470.082% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -245.639% |
| Senti Biosciences, Inc. | -92.72 Million USD | -380.801% |
| Mesoblast Limited | -58.79 Million USD | -658.296% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -169.336% |
| ChromaDex Corporation | -5.59 Million USD | -7862.717% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -9204.72% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -863.837% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -5443.866% |
| Seer, Inc. | -103.46 Million USD | -330.91% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -913.025% |
| Novavax, Inc. | -566.51 Million USD | 21.302% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -2741.546% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -134.019% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -754.937% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -81.603% |
| Celcuity Inc. | -66.23 Million USD | -573.155% |
| ContextLogic Inc. | -328 Million USD | -35.925% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -166.468% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -356.356% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 177.056% |
| Amarin Corporation plc | -67.58 Million USD | -559.633% |
| AnaptysBio, Inc. | -164.41 Million USD | -171.17% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1443.848% |
| Aptorum Group Limited | -10.52 Million USD | -4136.61% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -415.914% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -117.477% |
| Ardelyx, Inc. | -63.27 Million USD | -604.584% |
| Celularity Inc. | -192.28 Million USD | -131.858% |
| Omeros Corporation | -164.53 Million USD | -170.973% |
| Humacyte, Inc. | -100.04 Million USD | -345.623% |
| Immunocore Holdings plc | -59.64 Million USD | -647.427% |
| IO Biotech, Inc. | -91.44 Million USD | -387.552% |
| GT Biopharma, Inc. | -13.57 Million USD | -3183.975% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -497.15% |
| Summit Therapeutics Inc. | -89.73 Million USD | -396.827% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1201.055% |
| Pulmatrix, Inc. | -14.74 Million USD | -2924.644% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 13.479% |
| Evogene Ltd. | -26.39 Million USD | -1589.335% |
| CorMedix Inc. | -48.95 Million USD | -810.647% |
| BioLineRx Ltd. | -49.69 Million USD | -797.156% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1250.148% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1350.333% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -27.599% |
| scPharmaceuticals Inc. | -55.39 Million USD | -704.81% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -302.87% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 515.571% |
| NLS Pharmaceutics AG | -11.8 Million USD | -3675.981% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1734.203% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -157.9% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -1976.924% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -1634.217% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -288.447% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -436.805% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -739.192% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -2259.19% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1345.636% |
| bluebird bio, Inc. | -244.26 Million USD | -82.522% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 329.289% |
| DBV Technologies S.A. | -76.43 Million USD | -483.306% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -89.234% |
| Galecto, Inc. | -39.9 Million USD | -1017.235% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -1102.872% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -757.486% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -103.371% |
| GlycoMimetics, Inc. | -39.27 Million USD | -1035.147% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -84.915% |
| ADMA Biologics, Inc. | 21.63 Million USD | 2160.986% |
| Clene Inc. | -40.54 Million USD | -999.735% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -27.359% |
| Aptose Biosciences Inc. | -52.35 Million USD | -751.54% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -2991.599% |
| Soligenix, Inc. | -7.69 Million USD | -5691.582% |
| Century Therapeutics, Inc. | -146.54 Million USD | -204.227% |
| Kura Oncology, Inc. | -165.8 Million USD | -168.891% |
| Surrozen, Inc. | -45.78 Million USD | -873.859% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -377.04% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -17865.244% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -6775.887% |
| Autolus Therapeutics plc | -195.02 Million USD | -128.599% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -426.634% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -2009.451% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -284.143% |
| GRI Bio, Inc. | -11.38 Million USD | -3815.276% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -9772.911% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -510.905% |
| INmune Bio, Inc. | -29.74 Million USD | -1399.05% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -303.049% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1070.923% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2690.052% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -5314.57% |
| Jaguar Health, Inc. | -34.29 Million USD | -1200.144% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -2726.944% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -629.701% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1694.528% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -61.53% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -119.407% |
| Verastem, Inc. | -92.08 Million USD | -384.158% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -142.109% |
| Histogen Inc. | -10.64 Million USD | -4088.974% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -2781.552% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -507.575% |
| Surrozen, Inc. | -45.78 Million USD | -873.859% |
| Organovo Holdings, Inc. | -15.08 Million USD | -2855.273% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -8658.582% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -5740.976% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -160.29% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -820.23% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -2829.105% |
| Kronos Bio, Inc. | -121.83 Million USD | -265.946% |
| Turnstone Biologics Corp. | -59.03 Million USD | -655.239% |
| Synaptogenix, Inc. | -8.31 Million USD | -5262.525% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -2956.578% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -13999.7% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -386.234% |
| Exelixis, Inc. | 170.88 Million USD | 360.896% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -187.517% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 13.786% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -547.438% |
| ESSA Pharma Inc. | -32.13 Million USD | -1287.412% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -2503.698% |
| Avid Bioservices, Inc. | -18.67 Million USD | -2286.939% |
| Insmed Incorporated | -709.62 Million USD | 37.174% |
| MediWound Ltd. | -15.29 Million USD | -2815.844% |
| OmniAb, Inc. | -69.41 Million USD | -542.234% |
| Alector, Inc. | -151.74 Million USD | -193.813% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -312.873% |
| Zai Lab Limited | -366.57 Million USD | -21.622% |
| AlloVir, Inc. | -181.33 Million USD | -145.867% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -40.74% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -302.449% |
| Aura Biosciences, Inc. | -84.99 Million USD | -424.564% |
| Immunic, Inc. | -99.22 Million USD | -349.324% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -211.427% |
| Veracyte, Inc. | -85.79 Million USD | -419.649% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -58.2% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3037.456% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 613.561% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -6372.647% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -2272.381% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -1651.591% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1248.994% |
| Fortrea Holdings Inc. | 63.1 Million USD | 806.549% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -217.443% |
| XBiotech Inc. | -37.51 Million USD | -1088.57% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -547.438% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -162.345% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -1077.302% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -564.232% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -313.167% |
| Agenus Inc. | -159.54 Million USD | -179.433% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1636.649% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -736.584% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 21.675% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -467.997% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -329.888% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -1903.459% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -220.671% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -7832.776% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -1651.178% |
| Lantern Pharma Inc. | -17.87 Million USD | -2393.809% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -936.82% |
| Ainos, Inc. | -13.2 Million USD | -3275.883% |
| Pluri Inc. | -22.15 Million USD | -1912.061% |
| Prothena Corporation plc | -191.03 Million USD | -133.376% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -222.978% |
| Rallybio Corporation | -78.93 Million USD | -464.831% |
| Kodiak Sciences Inc. | -277.32 Million USD | -60.764% |
| Cue Biopharma, Inc. | -52.14 Million USD | -754.921% |
| MeiraGTx Holdings plc | -137.06 Million USD | -225.28% |
| Annexon, Inc. | -143.72 Million USD | -210.203% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -589.652% |
| Moderna, Inc. | -4.23 Billion USD | 89.483% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -2302.244% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -1720.988% |
| Blueprint Medicines Corporation | -486.27 Million USD | 8.317% |
| Immix Biopharma, Inc. | -16.14 Million USD | -2662.093% |
| CalciMedica, Inc. | -21.87 Million USD | -1938.091% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -211.094% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -160.272% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -555.675% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -36.382% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -1147.258% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -559.994% |
| Nutriband Inc. | -4.87 Million USD | -9051.052% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -922.247% |
| Vor Biopharma Inc. | -126.03 Million USD | -253.734% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 110.51% |
| Alkermes plc | 414.12 Million USD | 207.657% |
| ProKidney Corp. | -151.52 Million USD | -194.236% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -590.838% |
| Arcellx, Inc. | -89.88 Million USD | -396.031% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 26.596% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -290.489% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -1071.025% |
| Atai Life Sciences N.V. | -125.47 Million USD | -255.327% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -446.1% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -447.645% |
| MediciNova, Inc. | -9.9 Million USD | -4403.238% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -252.791% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -6055.817% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1567.104% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -92.314% |
| Biomea Fusion, Inc. | -126.13 Million USD | -253.457% |
| RenovoRx, Inc. | -11.39 Million USD | -3812.184% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -133.311% |
| Geron Corporation | -193.94 Million USD | -129.877% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1516.096% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -295.007% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -84.105% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -1669.457% |
| Royalty Pharma plc | 1.49 Billion USD | 129.879% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -114.349% |
| Imunon, Inc. | -21.03 Million USD | -2019.94% |
| BioAtla, Inc. | -129.68 Million USD | -243.776% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -36.034% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -967.658% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -160.786% |
| Structure Therapeutics Inc. | -102.77 Million USD | -333.795% |
| 89bio, Inc. | -151.2 Million USD | -194.855% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -323.646% |
| aTyr Pharma, Inc. | -54.91 Million USD | -711.8% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -409.948% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -75.214% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -5328.538% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2552.817% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5041526.026% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 232.07% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -159.582% |
| Liquidia Corporation | -73.38 Million USD | -507.534% |
| Entera Bio Ltd. | -8.89 Million USD | -4914.425% |
| GH Research PLC | -41.22 Million USD | -981.54% |
| Vericel Corporation | -6.46 Million USD | -6797.161% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -470.826% |
| Xencor, Inc. | -138.63 Million USD | -221.578% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -8549.245% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2690.052% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -1974.496% |
| Vaxcyte, Inc. | -468.04 Million USD | 4.745% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -108.28% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -3095.474% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -6723.248% |
| Portage Biotech Inc. | -18.25 Million USD | -2342.516% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -6055.817% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -324.76% |
| OncoCyte Corporation | -25.13 Million USD | -1673.681% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -3843.725% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -3791.334% |
| Purple Biotech Ltd. | 22.27 Million USD | 2101.852% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1429.075% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1421.353% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -141.831% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -5834.937% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1404.615% |
| United Therapeutics Corporation | 1.18 Billion USD | 137.626% |
| HilleVax, Inc. | -133.34 Million USD | -234.345% |
| Silo Pharma, Inc. | -3.85 Million USD | -11463.27% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -11209.667% |
| Pharming Group N.V. | -4.87 Million USD | -9036.766% |
| Tharimmune, Inc. | -9.45 Million USD | -4615.2% |
| Genprex, Inc. | -31.07 Million USD | -1334.672% |
| Apogee Therapeutics, Inc. | -93 Million USD | -379.374% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -136.9% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -442.402% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -58178.758% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -8085.04% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2830631.079% |
| Savara Inc. | -60 Million USD | -642.967% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -2441.949% |
| Curis, Inc. | -48.33 Million USD | -822.438% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -8445.305% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1536.083% |
| BeiGene, Ltd. | -1.2 Billion USD | 63.085% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -376.052% |
| Erasca, Inc. | -141.52 Million USD | -215.02% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -9748.356% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -9748.356% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -946.334% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -6909.945% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -563.076% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -188.486% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -114.209% |
| Adicet Bio, Inc. | -152.03 Million USD | -193.238% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -506.624% |
| Aditxt, Inc. | -26.06 Million USD | -1610.633% |
| Adagene Inc. | -23.71 Million USD | -1779.574% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5998.858% |
| Quantum-Si incorporated | -111.17 Million USD | -301.033% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -2958.304% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 465.395% |
| Compugen Ltd. | -12.99 Million USD | -3331.593% |
| Generation Bio Co. | -138.56 Million USD | -221.754% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -436.954% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -415.652% |
| Invivyd, Inc. | -207.78 Million USD | -114.566% |
| Relay Therapeutics, Inc. | -373 Million USD | -19.526% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -4653.77% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 2175.474% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4233.941% |
| 2seventy bio, Inc. | -216.7 Million USD | -105.734% |
| Instil Bio, Inc. | -159.16 Million USD | -180.1% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -1751.629% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -12051.097% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1567.104% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -1113.744% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -329.917% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -161.826% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 34.849% |
| Evaxion Biotech A/S | -22.19 Million USD | -1908.526% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -441.177% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -99.814% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -457.674% |
| Cingulate Inc. | -22.75 Million USD | -1858.912% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 6050.781% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -898.125% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -618.227% |
| Clearmind Medicine Inc. | -8.74 Million USD | -5000.271% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -485.113% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -15100.64% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -342.176% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -17.171% |
| ImmunityBio, Inc. | -362.25 Million USD | -23.073% |
| Korro Bio, Inc. | -84.53 Million USD | -427.4% |
| Kineta, Inc. | -15.72 Million USD | -2735.543% |
| BioVie Inc. | -32.17 Million USD | -1285.451% |
| Codexis, Inc. | -68.06 Million USD | -554.971% |
| Celularity Inc. | -192.28 Million USD | -131.858% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -2639.202% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -100.277% |
| Virax Biolabs Group Limited | -6.49 Million USD | -6762.685% |
| Cibus, Inc. | -318.88 Million USD | -39.811% |
| IN8bio, Inc. | -30.33 Million USD | -1369.6% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -260.149% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -1801.691% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -26.038% |
| Eyenovia, Inc. | -25.4 Million USD | -1654.801% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1465.908% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -7915.687% |
| Elevation Oncology, Inc. | -45.44 Million USD | -881.038% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -463.396% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -881.75% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -224.934% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1333.13% |
| Moolec Science SA | -6.65 Million USD | -6600.414% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -629.223% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -930.755% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -171.581% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -785.238% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -4679.577% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -1936.261% |
| Humacyte, Inc. | -100.04 Million USD | -345.623% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -456.373% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -2966.248% |
| Genelux Corporation | -24.16 Million USD | -1744.951% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1214.248% |
| Notable Labs, Ltd. | -14.65 Million USD | -2941.772% |
| Immunovant, Inc. | -282.7 Million USD | -57.7% |
| Quantum-Si incorporated | -111.17 Million USD | -301.033% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -1996.358% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -337.039% |
| Acasti Pharma Inc. | -11.31 Million USD | -3841.235% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -1845.074% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -977.306% |
| PepGen Inc. | -84.76 Million USD | -425.957% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1847.122% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1258.909% |
| Immuneering Corporation | -58.41 Million USD | -663.243% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -8658.582% |
| Belite Bio, Inc | -31.66 Million USD | -1307.833% |
| XOMA Corporation | -41.84 Million USD | -965.362% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -560.297% |
| Bionomics Limited | -17.89 Billion USD | 97.508% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1349.531% |
| uniQure N.V. | -282.87 Million USD | -57.61% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5998.858% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -244.262% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1272.384% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -5265.816% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1416.695% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -7915.687% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3037.456% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -4915.553% |
| Altimmune, Inc. | -95.92 Million USD | -364.753% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -509.811% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1349.531% |
| Peak Bio, Inc. | -1356.23 USD | -32872827.306% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -798.783% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1882.359% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -83.998% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1398.798% |
| Zura Bio Limited | -62.63 Million USD | -611.76% |
| PolyPid Ltd. | -22.86 Million USD | -1849.676% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1398.798% |
| argenx SE | -425.04 Million USD | -4.89% |
| Immunome, Inc. | -109.53 Million USD | -307.041% |
| Verona Pharma plc | -67.83 Million USD | -557.271% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -1610.792% |
| Shattuck Labs, Inc. | -91.95 Million USD | -384.827% |
| CervoMed Inc. | -7.81 Million USD | -5606.368% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -3246.84% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -825.463% |
| Moolec Science SA | -6.65 Million USD | -6600.414% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -2610.485% |
| Design Therapeutics, Inc. | -78.19 Million USD | -470.191% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -412.21% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -1000.848% |
| Achilles Therapeutics plc | -75.25 Million USD | -492.429% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -15100.64% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -704.041% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -777.002% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -574.492% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -723.738% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -881.815% |
| Beam Therapeutics Inc. | -176.48 Million USD | -152.618% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -308.444% |
| AEON Biopharma, Inc. | -48.42 Million USD | -820.59% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -519.789% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -433.746% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -3442.037% |
| NeurAxis, Inc. | -6.66 Million USD | -6589.667% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 3.198% |
| Lumos Pharma, Inc. | -36.61 Million USD | -1117.656% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 8746.346% |
| Palisade Bio, Inc. | -13.07 Million USD | -3311.113% |
| Nutriband Inc. | -4.87 Million USD | -9051.052% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -515.459% |
| Neurogene Inc. | -55.58 Million USD | -702.102% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -5144.471% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -360.999% |
| Athira Pharma, Inc. | -125.46 Million USD | -255.341% |
| HCW Biologics Inc. | -25.71 Million USD | -1633.599% |
| XOMA Corporation | -41.84 Million USD | -965.362% |
| Nektar Therapeutics | -137.42 Million USD | -224.419% |
| Arvinas, Inc. | -401.5 Million USD | -11.042% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -5041526.026% |
| Merus N.V. | -156.54 Million USD | -184.791% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -344.672% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -1187.789% |
| Rezolute, Inc. | -70.42 Million USD | -533.078% |
| Clene Inc. | -40.54 Million USD | -999.735% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -2622.064% |
| BeyondSpring Inc. | -23.11 Million USD | -1828.842% |
| Synlogic, Inc. | -55.16 Million USD | -708.239% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -2386.656% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4018.926% |
| Peak Bio, Inc. | -1356.23 USD | -32872827.306% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -1000.739% |
| Krystal Biotech, Inc. | -109.72 Million USD | -306.311% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -244.166% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -29.975% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -9293.951% |
| MannKind Corporation | 8.67 Million USD | 5237.503% |
| Ikena Oncology, Inc. | -75.41 Million USD | -491.157% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -4521.463% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -563.145% |
| Gossamer Bio, Inc. | -183.75 Million USD | -142.618% |
| CohBar, Inc. | -12.38 Million USD | -3498.82% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -778.938% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1516.096% |
| Legend Biotech Corporation | -439.48 Million USD | -1.444% |
| Mural Oncology plc | -194.63 Million USD | -129.057% |
| Disc Medicine, Inc. | -91.12 Million USD | -389.254% |
| Champions Oncology, Inc. | -7.35 Million USD | -5960.801% |
| REGENXBIO Inc. | -268.12 Million USD | -66.276% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -4059.589% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -699.613% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -1044.315% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -289.86% |
| Vaxart, Inc. | -83.34 Million USD | -434.911% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -5132.771% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -941.809% |
| Cellectis S.A. | -106.62 Million USD | -318.127% |
| Longeveron Inc. | -21.02 Million USD | -2020.084% |
| Repare Therapeutics Inc. | -116.22 Million USD | -283.598% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -66.465% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -489.375% |
| Revolution Medicines, Inc. | -487.18 Million USD | 8.488% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -6602.232% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -914.316% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -497.711% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -540.242% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -3948.974% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 110.35% |
| Denali Therapeutics Inc. | -196.69 Million USD | -126.657% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -5050.165% |
| Veru Inc. | -93.78 Million USD | -375.391% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -1811.066% |
| Cingulate Inc. | -22.75 Million USD | -1858.912% |
| Passage Bio, Inc. | -108.38 Million USD | -311.326% |
| Context Therapeutics Inc. | -25.07 Million USD | -1678.165% |
| Exicure, Inc. | -14.99 Million USD | -2873.009% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -116.356% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -998.164% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -4488.2% |
| Nuvalent, Inc. | -149.49 Million USD | -198.232% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -5326.057% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -402.454% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -2046.108% |
| OmniAb, Inc. | -69.41 Million USD | -542.234% |
| Anew Medical, Inc. | -1.3 Million USD | -34172.662% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -3390.976% |
| Lipocine Inc. | -17.93 Million USD | -2386.384% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -550.727% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -485.451% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1070.923% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -1027.919% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -1891.746% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 23.112% |
| Ocugen, Inc. | -65.53 Million USD | -580.338% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -374.967% |
| Q32 Bio Inc. | -92.1 Million USD | -384.064% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -1979.54% |
| Alumis Inc. Common Stock | -158.17 Million USD | -181.862% |
| Equillium, Inc. | -14.52 Million USD | -2970.049% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -614.406% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -5541.058% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2263.265% |
| Dominari Holdings Inc. | -21.79 Million USD | -1945.479% |
| Edesa Biotech, Inc. | -9.22 Million USD | -4734.047% |
| vTv Therapeutics Inc. | -25.5 Million USD | -1648.226% |
| Bio-Techne Corporation | 206.68 Million USD | 315.705% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -13.882% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 332.168% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -237.045% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -1061.294% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -195.056% |
| Nkarta, Inc. | -131.65 Million USD | -238.65% |
| BioCardia, Inc. | -11.64 Million USD | -3728.86% |
| Iterum Therapeutics plc | -47.46 Million USD | -839.227% |